Effects of the oral monophasic contraceptive pill CG 5025 (Belara/0,03 mg etinyl estradiol and 2 mg chlormadinonacetate) on the cosmetic hairquality in women wishing to use hormonal contraceptio
- Conditions
- unaesthetic hairquality in woman wishing to use hormonal contraception
- Registration Number
- EUCTR2007-007489-39-DE
- Lead Sponsor
- niversity of Hamburg, MIN-Faculty, Department of Chemistry, Division of Cosmetetic Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Female
- Target Recruitment
- Not specified
•age >18 and <45;
•woman wishing to use hormonal contraception;
•dissatisfaction with the own hairquality;
•written informed consent;
•gynaecological confirmation that participation is medically unobjectionable (not older
than 4 weeks)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
•pregnancy, lactation;
•alkoholism, drug addiction;
•participation on other clinical trials at the same time or within the last 30 days;
•taking hormonal contraception within the last 4 weeks or especially antiandrogenetic
contraception within the last 3 month
•no written informed consent;
•no gynaecological confirmation that participation is medically unobjectionable
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method